Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2013 2
2014 2
2015 3
2016 5
2017 8
2018 4
2019 6
2020 9
2021 5
2022 10
2023 8
2024 4
2025 4
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study.
Tamborlane WV, Laffel LM, Shehadeh N, Isganaitis E, Van Name M, Ratnayake J, Karlsson C, Norjavaara E. Tamborlane WV, et al. Among authors: van name m. Lancet Diabetes Endocrinol. 2022 May;10(5):341-350. doi: 10.1016/S2213-8587(22)00052-3. Epub 2022 Apr 1. Lancet Diabetes Endocrinol. 2022. PMID: 35378069 Free PMC article. Clinical Trial.
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
Forlenza GP, McVean J, Beck RW, Bauza C, Bailey R, Buckingham B, DiMeglio LA, Sherr JL, Clements M, Neyman A, Evans-Molina C, Sims EK, Messer LH, Ekhlaspour L, McDonough R, Van Name M, Rojas D, Beasley S, DuBose S, Kollman C, Moran A; CLVer Study Group. Forlenza GP, et al. Among authors: van name m. JAMA. 2023 Mar 28;329(12):990-999. doi: 10.1001/jama.2023.2064. JAMA. 2023. PMID: 36826844 Free PMC article.
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.
Haller MJ, Kanapka L, Monzavi R, Mouse TJ, Prakasam G, Dewan AK, DiMeglio LA, Laffel LM, Willi SM, Tansey MJ, Nelson BA, Kashmiri H, Wood JR, Latif K, White P, Kipnes M, Rodriguez H, Smith J, Sparling DP, Malik FS, Cymbaluk A, Bhargava A, Ekhlaspour L, Beasley S, Cossen K, Wintergerst KA, Fiallo-Scharer R, Maahs DM, Bethin KE, Wood MA, Hanley PC, Mulukutla SN, Van Name M, Blackman SM, Gallagher MP, Clements MA, Sheanon N, Reddy K, Reiner BJ, Gal R, Beck RW; INHALE-1 Study Group*. Haller MJ, et al. Among authors: van name m. Diabetes Care. 2026 Jan 1;49(1):179-187. doi: 10.2337/dc25-1994. Diabetes Care. 2026. PMID: 41223151 Free PMC article. Clinical Trial.
Pharmacologic treatment options for type 1 diabetes: what's new?
Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV. Nally LM, et al. Among authors: van name ma. Expert Rev Clin Pharmacol. 2019 May;12(5):471-479. doi: 10.1080/17512433.2019.1597705. Expert Rev Clin Pharmacol. 2019. PMID: 30892094 Free PMC article. Review.
The present and future treatment of pediatric type 2 diabetes.
Van Name MA, Guandalini C, Steffen A, Patel A, Tamborlane W. Van Name MA, et al. Expert Rev Endocrinol Metab. 2018 Jul;13(4):207-212. doi: 10.1080/17446651.2018.1499467. Epub 2018 Jul 23. Expert Rev Endocrinol Metab. 2018. PMID: 30063424 Review.
66 results